This week’s podcast includes discussion of Medtronic’s latest sales and earnings report and an update on Freenome’s multiomics liquid biopsy test for early-stage colorectal cancer.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode:
Medtronic ‘Plays Offense’ Despite Pandemic Challenges, Q1 Results Provide Optimism
https://bit.ly/3b2c1iB
ADA 2020: Medtronic Explains Strategy To Return Growth To Diabetes Business
https://bit.ly/3dkyCX4
Freenome Raises $270M In Series C, Accelerates Trial For Colorectal Cancer Test
https://bit.ly/32xADfd
Freenome Scores $160M In New Funding. So What's Next?
https://bit.ly/32zzKCK